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A B S T R A C T
Background
Tuberculous sputum provides a sample of bacilli that must be eliminated by chemotherapy
and that may go on to transmit infection. A preliminary observation that Mycobacterium
tuberculosis cells contain triacylglycerol lipid bodies in sputum, but not when growing in vitro,
led us to investigate the extent of this phenomenon and its physiological basis.
Methods and Findings
Microscopy-positive sputum samples from the UK and The Gambia were investigated for
their content of lipid body–positive mycobacteria by combined Nile red and auramine staining.
All samples contained a lipid body–positive population varying from 3% to 86% of the acid-fast
bacilli present. The recent finding that triacylglycerol synthase is expressed by mycobacteria
when they enter in vitro nonreplicating persistence led us to investigate whether this state was
also associated with lipid body formation. We found that, when placed in laboratory conditions
inducing nonreplicating persistence, two M. tuberculosis strains had lipid body levels
comparable to those found in sputum. We investigated these physiological findings further
by comparing the M. tuberculosis transcriptome of growing and nonreplicating persistence
cultures with that obtained directly from sputum samples. Although sputum has traditionally
been thought to contain actively growing tubercle bacilli, our transcript analyses refute the
hypothesis that these cells predominate. Rather, they reinforce the results of the lipid body
analyses by revealing transcriptional signatures that can be clearly attributed to slowly
replicating or nonreplicating mycobacteria. Finally, the lipid body count was highly correlated
(R2¼ 0.64, p , 0.03) with time to positivity in diagnostic liquid cultures, thereby establishing a
direct link between this cytological feature and the size of a potential nonreplicating
population.
Conclusion
As nonreplicating tubercle bacilli are tolerant to the cidal action of antibiotics and resistant to
multiple stresses, identification of this persister-like population of tubercle bacilli in sputum
presents exciting and tractable new opportunities to investigate both responses to chemo-
therapy and the transmission of tuberculosis.
The Editors’ Summary of this article follows the references.
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Introduction
Mycobacterium tuberculosis infects one in three worldwide and
kills more people each year than any other bacterial
pathogen. Routine treatment of tuberculosis requires combi-
nation antibiotic therapy for a minimum of six months, and
places a substantial burden on health care systems, partic-
ularly in resource-poor countries. Over eight million new
cases every year testify to this obligate pathogen’s ongoing
success in transmission [1], yet we know little about what the
organism needs to achieve this essential step.
Expectorated tubercle bacilli have been thought to
originate from rapid and extensive bacterial growth at the
margins of liqueﬁed lesions in the lung [2,3]. Sputum provides
a tractable sample of the bacterial population that must be
targeted by antibiotic therapy and a snapshot of the organism
on its way to a new host. It follows that the bacilli in
microscopy smear-positive tuberculosis sputum express
properties required for transmission—properties that might
explain the existence of drug-tolerant persister subpopula-
tions and account for the prolonged antibiotic therapy
necessary for relapse-free treatment [4]. Since transmission
is required for evolutionary survival, we may assume that M.
tuberculosis experiences powerful selection pressures to main-
tain and express these as-yet unidentiﬁed properties. Thus,
any bacillary phenotype recognised preferentially in sputum
could provide clues to these properties.
We have previously shown that nonpathogenic mycobac-
teria readily accumulate intracellular triacylglycerol lipid
bodies in vitro [5]; these bodies could not be demonstrated
under similar conditions with M. tuberculosis, yet anecdotally
have been seen in acid-fast bacilli (AFB) in tuberculous
sputum [5]. The recent discovery of a novel class of
diacylglycerol acyl transferase enzymes in Acinetobacter [6]
and the subsequent characterisation of 15 members of this
class as triacylglycerol synthase-encoding genes (tgs1–tgs15) in
M. tuberculosis [7] provide a biochemical basis for the presence
of lipid bodies in this organism. Intriguingly, Tgs1, the most
active of these enzymes, is a member of the DosR regulon [8],
a set of genes responsive to hypoxia and linked to long-term
survival ofM. tuberculosis in animal hosts [9–13]. It has recently
been shown that triacylglycerol is accumulated by M. tuber-
culosis following hypoxic and other stresses [7,14] and may
contribute to long-term mycobacterial survival. These obser-
vations raise the possibility that lipid body–positive cells in
sputum may be in a nonreplicating persistent (NRP) state,
which, given that NRP bacilli display antibiotic tolerance
[11,13,15], would have implications for chemotherapy.
Deﬁning the phenotypes of bacterial pathogens in their
natural environments remains a key challenge. Accurate
knowledge of the properties expressed at different stages of
infection enables precise targeting of therapeutic and
preventive measures. While much has been learnt about
bacterial pathogens from in vitro and in vivo (animal model)
transcriptome studies [16,17] as well as from human lung
tissue [18], there have, to the best of our knowledge, been no
published studies of transcript proﬁles in sputum samples—a
clinically tractable sample. Such methods as rapidly stabilised
RNA, differential cell lysis, and RNA ampliﬁcation have
enabled us to report here the transcriptome of M. tuberculosis
in the sputum of patients prior to treatment.
Methods
Patients
Patients attending the public clinic at the MRC Laborato-
ries, Fajara, The Gambia and identiﬁed as sputum smear–
positive by routine microscopy were invited to provide early-
morning samples for transcriptome analysis. Patients who
agreed to participate gave informed oral consent (study nos.
L2002.52 and L2006.60, ethical committee, MRC Laborato-
ries, Fajara, The Gambia). Sputum from nine patients yielded
sufﬁcient mycobacterial RNA for analysis by microarray or
PCR; these were designated sputum samples 1–9.
Mycobacterial Strains and Growth Conditions
M. tuberculosis complex for direct microarray transcriptome
analysis was isolated from an aliquot of sputum 1 using
standard methods [19]. M. tuberculosis complex was grown on
7H10 agar with oleic acid-albumin-dextrose-catalase [20]
supplement or in 7H9 broth with albumin-dextrose-catalase
supplement [20], 0.2% glycerol and 0.05% Tween-80. For
hypoxic (nonreplicating persistence) cultures M. tuberculosis
strains H37Rv and CH [21] were grown in Dubos Tween-
albumin broth.
Routine Culturing of Smear-Positive Sputum Samples
Diagnostic sputum specimens were stained with auramine-
phenol [19], and positive smears conﬁrmed and scored by
Ziehl-Neelsen staining after initial examination by ﬂuores-
cence microscopy. Smears were scored as either 1þ (1–10 AFB
in 100 ﬁelds of view), 2þ (1–10 AFB in ten ﬁelds of view), or 3þ
(1–10 AFB in one ﬁeld of view). Decontamination of speci-
mens was performed by the NaOH-NALC method [19]. Each
decontaminated specimen was inoculated into one vial of
BACTEC 9000 MB medium for isolation ofM. tuberculosis. The
time to positivity of the BACTEC culture was recorded in
days. All mycobacterial cultures were identiﬁed and con-
ﬁrmed as M. tuberculosis complex using standard procedures.
Auramine-Nile Red Labelling of Sputum Samples
Whole sputum (;1–4 ml) was digested for 15 min with an
equal volume of 0.5% w/v N-acetyl L-cysteine in 50 mM
sodium citrate [19]. Phosphate buffer (67 mM [pH 6.8]) was
added to a ﬁnal volume of 20 ml, and bacteria were
concentrated (1,398g, 20 min). The pellet was resuspended
in 0.5 ml of phosphate-buffered saline and a smear prepared
with ;10 ll of the suspension. Heat-ﬁxed smears were
labelled with auramine-Nile red as previously described [5].
Preparations were observed by epiﬂuorescence microscopy
using a Nikon Diphot 300 inverted microscope with a 100 W
mercury light source. Images were recorded using a 12/10bit,
high speed Peltier-cooled CCD camera (FDI, Photonic
Science) using Image-Pro Plus (Media Cybernetics) software.
The 11001V2 Blue (excitation 470 6 40 nm; emission . 515
nm; Chroma Technology) and the G-2A (excitation 510–560
nm; emission: 590 6 10 nm, Nikon) ﬁlter sets were used for
epiﬂuorescence microscopy.
Nile Red Labelling of Nonreplicating Persistence M.
tuberculosis Cultures
M. tuberculosis H37Rv and strain CH [21] were grown as
agitated, aerated cultures (370 rpm) to mid-log phase in
Dubos liquid medium, supplemented with Dubos medium
albumin. M. tuberculosis NRP1/2 (nonreplicating persistence
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stage 1 and 2) cultures were incubated with continuous
stirring at 37 8C for 168, 288, and 504 h, respectively,
according to Wayne and Hayes [15]. At these time points one
tube of each culture was destructively sampled for micro-
scopic analysis. 10 ll of each sample was spread on a slide,
heat ﬁxed, and labelled with Nile red as previously described
[5].
RNA Extraction from Tuberculous Sputa
With the exception of sputum sample 1, which was frozen
in liquid nitrogen within 10 min of expectoration, approx-
imately four volumes of GTC solution (5 M guanidinium
thiocyanate, 0.5% w/v sodium N-lauryl sarcosine, 25 mM
trisodium citrate, 0.1 M 2-mercaptoethanol, 0.5% w/v Tween
80 [pH 7.0]) [22] were added to sputum within 5 min of
collection. Mycobacteria were harvested by centrifugation
(1398g, 30 min), resuspended in 400 ll of sterile deionized
water, and added to 1 ml of Trizol LS (Invitrogen). RNA was
extracted using a method modiﬁed from that of DesJardin et
al. [23] with chloroform replacing chloroform:isoamyl alcohol
washes and the Cleanascite step omitted. The mixture was
transferred to a glass matrix tube for cell lysis (Lysing matrix
B; Q-Biogene) and processed in a spin/rotation instrument
for cell lysis (Ribolyser; Hybaid), with a speed setting of 6.5
and a time setting of 45 s. After processing, 200 ll of
chloroform was added to the mixture and it was vortex-mixed
for 2 min. The aqueous and organic layers were separated by
microcentrifugation for 15 min at room temperature at
16,000g. The aqueous phase containing the RNA was washed
once with an equal volume of chloroform. The aqueous phase
was removed to a fresh tube and 1 ll of glycoblue (Ambion),
0.1 volume of 5 M ammonium acetate, and an equal volume of
isopropanol were added. The RNA was precipitated over-
night at 20 8C. The resulting RNA pellet was washed once
with 70% v/v and once with 95% v/v ethanol, dried and
resuspended in 100 ll of RNase-free H2O (Sigma). The
cognate M. tuberculosis complex isolate from sputum sample 1
was cultured for 6 d in 100ml 7H9 broth at 37 8C, 200 rpm at
which time the absorbance was 0.22 at 580 nm. Mycobacterial
RNA was stabilised with GTC solution and extracted as
previously described. Total RNA from sputum samples (5, 7,
8, and 9) for ampliﬁcation was quantiﬁed using the Nano-
Drop ND-1000 Spectrophotometer (NanoDrop Technologies)
and Agilent 2100 Bioanalyser (Agilent Technologies).
Microarray Analysis of RNA from Sputum 1
RNA from sputum 1 and the in vitro-grown cognate isolate
was cleaned using the RNeasy kit (Qiagen). A M. tuberculosis
whole genome microarray, generated by the Bacterial Micro-
array Group at St. George’s (University of London) and
consisting of 3,924 gene-speciﬁc PCR products (designed with
minimal cross-homology) to the M. tuberculosis H37Rv [24],
was utilised (ArrayExpress accession number A-BUGS-1;
http://bugs.sgul.ac.uk/A-BUGS-1). Hybridisations were con-
ducted as previously described [25] with 15 lg of Cy5-labelled
cDNA derived from M. tuberculosis RNA against 1 lg Cy3-
labelled M. tuberculosis H37Rv genomic DNA. The hybridised
slides were scanned sequentially at 532 nm and 635 nm
corresponding to Cy3 and Cy5 excitation maxima using the
Affymetrix 428 Array Scanner (MWG). Comparative spot
intensities from the images were calculated using Imagene 5.5
(BioDiscovery), and imported into GeneSpring GX 7.2
(Agilent Technologies) for further analysis. After local back-
ground subtraction the measured intensity in the cDNA
channel for each gene was divided by its intensity in the
genomic DNA control channel. The array data were
normalised to the 50th percentile of all genes detected to
be present on the array and ﬁltered to remove unreliable low
intensity data (below a value of 500 in either channel).Genes
were identiﬁed as differentially expressed in sputum with a
cut-off of .3-fold relative to in vitro growth.
Growth Conditions and RNA Extraction for Microarray
Analysis
M. tuberculosis H37Rv was grown as agitated, aerated
cultures (370 rpm) to mid-log phase at 37 8C in Dubos liquid
medium, supplemented with Dubos medium albumin. M.
tuberculosis NRP1/2 cultures were set up and cultured in a
stirred model for 72 h and 240 h, respectively, according to
Wayne and Hayes [15]. Mycobacterial RNA was extracted
from in vitro models (collected straight into GTC solution)
using the GTC/Trizol method as developed by Mangan et al.
[26]; RNA was DNase-treated and puriﬁed using RNeasy
columns (Qiagen). Total RNA was quantiﬁed using the
NanoDrop ND-1000 Spectrophotometer (NanoDrop Tech-
nologies) and Agilent 2100 Bioanalyser (Agilent Technolo-
gies).
RNA Amplification
An aliquot of 5 ng of total M. tuberculosis RNA was ampliﬁed
using an Eberwine T7-oligo-dT based system after an initial
polyadenylation step (MessageAmp II Bacteria, Ambion).
Using this method, bacterial RNA was polyadenylated before
priming the ﬁrst-strand cDNA synthesis reaction with T7-
linked oligo-dT. Ampliﬁed RNA was generated after second-
strand cDNA synthesis and cDNA puriﬁcation by in vitro run-
off transcription (IVT) using T7 polymerase. Single rounds of
ampliﬁcation were performed, with an in vitro transcription
reaction of 16 h at 37 8C. This ampliﬁcation method has been
previously demonstrated to be reproducible and capable of
identifying representative changes in gene expression [27,28].
The yield and size distribution of ampliﬁed products was
assessed spectrophotometrically at OD260 and using the
Agilent 2100 Bioanalyser (Agilent Technologies).
Microarray Analyses of Samples 5, 7, 8, and 9
An M. tuberculosis whole-genome microarray, generated by
the Bacterial Microarray Group at St. George’s (ArrayExpress
accession number A-BUGS-23; http://bugs.sgul.ac.uk/
A-BUGS-23), and consisting of 4,410 gene-speciﬁc PCR
products (designed with minimal cross-homology) to the M.
tuberculosis H37Rv [24], CDC1551 [29], and M. bovis AF2122/97
[30] genomes was utilised. Hybridisations were conducted as
previously described [25] except for the use of M. tuberculosis
genomic DNA as a common reference [31]. Using genomic
DNA reduced technical variation between replicate hybrid-
isations and allowed RNA proﬁles to be used in multiple
comparisons. 5 lg of Cy5-labelled cDNA derived from
ampliﬁed M. tuberculosis RNA was hybridised with 2 lg of
Cy3-labelled M. tuberculosis H37Rv genomic DNA. A lower
ratio of test cDNA to comparator gDNA was used than with
sample 1, as we were able to conﬁrm the purity of our
preparations with the Bioanalyser at the same time and
perform technical replicates. The M. tuberculosis H37Rv
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reference DNA was kindly provided by Colorado State
University (http://www.cvmbs.colostate.edu/microbiology/tb/
top.htm). Two biological replicates of each in vitro growth
condition and four sputum samples (5, 7, 8, and 9) were
hybridised in triplicate. The microarrays were scanned and
spot intensities calculated as described above. The array data
were normalised to the 50th percentile of all genes detected
to be present on the array. The dataset was ﬁltered to include
only cDNA elements ﬂagged to be present on 80% of the
arrays. Signiﬁcantly differentially expressed genes were
identiﬁed using ANOVA (p , 0.05 with Benjamini and
Hochberg multiple testing correction) and a fold change of .
2.5. The signiﬁcantly differentially expressed genes were
hierarchically clustered using Cluster and the results dis-
played using Treeview software [32]. The hypergeometric
distribution was used to determine if functional categories of
genes were signiﬁcantly enriched in the sputum proﬁle [33].
Fully annotated microarray data are deposited in BlG@
Sbase and ArrayExpress.
Quantitative Real-Time RT-PCR
Mycobacterial RNA (0.5 lg) from sputum sample 1 and its
cognate isolate and eight further sputum samples (samples 2–
9) were reverse transcribed in a total volume of 30 ll using
random primers and Superscript II (Invitrogen Technologies)
according to manufacturer’s instructions. To estimate DNA
contamination of samples, all were subjected to a no reverse
transcriptase control, which was then subtracted from the
RNA result. A no-reverse transcriptase threshold of 10% of
the test value was taken, with the exception of four reactions
in which values which were ,20% were used for correction.
PCR reactions for tgs1 were set up using Absolute QPCR
SYBR green mix (ABgene), 0.4 lM primers [7] and 2 ll of
cDNA. PCR was performed using the Rotor-Gene RG-3000
system (Corbett Research) heating to 56 8C for 2 min, then 95
8C for 15 min, before 40 cycles of 95 8C for 30s, 60 8C for 30s,
and 72 8C for 30s, acquiring ﬂuorescence at 85 8C. No-reverse
transcriptase controls for both the sputum and isolate RNA
were included, and these showed no PCR product. PCR for
icl1 was set up with the primers of Dubnau et al. [34] using the
same cycling conditions and acquiring ﬂuorescence at 86 8C.
An hspX PCR was performed using primers of Wilkinson et al.
[35] with 40 cycles of 95 8C for 30s, 59 8C for 30s, 72 8C for 30s,
acquisition of ﬂuorescence at 85 8C. For normalisation, PCR
of sigA was performed using the primers of Manganelli et al.
[36], and cycling conditions used for tgs1 with ﬂuorescence
acquisition at 86 8C. PCRs for nuoB, qcrC, and ctaD were
performed using primers of Shi et al. [37] with conditions as
previously described with annealing steps performed at 61 8C,
56 8C, and 56 8C, and acquisition of ﬂuorescence at 84 8C, 82
8C, and 83 8C, respectively. The quantity of target DNA in
each cDNA sample was determined by the threshold cycle
(CT) with reference to a standard curve generated by the
ampliﬁcation of known amounts of M. tuberculosis H37Rv
genomic DNA.
Statistics
The proportion of lipid body–positive AFB and time to
positivity of routine cultures were analysed by linear
regression to provide R2 correlation coefﬁcients. As the lipid
body content of these samples was not normally distributed,
Pearson correlations were also performed.
Results
Lipid Body–Positive Acid-Fast Bacilli Are a Universal
Feature of Smear-Positive Tuberculous Sputum
If lipid body–positive cells are a transmission-adapted
phenotype for M. tuberculosis, then such cells should be
present in most smear-positive sputum samples. We conﬁrm
this hypothesis in 82 smear-positive samples from patients
from The Gambia and the UK (69 and 13, respectively). In
samples with .100 assessable bacilli, the frequency of lipid
body–positive cells varied from 3% to 86% (mean 45%,
standard deviation 20%), and these contained between two
and eight lipid bodies per cell (Figure 1). Thus, lipid body–
positive tubercle bacilli are readily demonstrable in smear-
positive samples from tuberculosis patients in two well-
separated geographic locations and are present in a
subpopulation of mycobacterial cells.
Lipid Bodies Are Readily Observed in M. tuberculosis Cells
in Nonreplicating Persistence
The discovery and characterisation of tgs1 [6,7] raised the
possibility that lipid bodies might be formed in response to the
hypoxic growth shift-down conditions that have been de-
scribed by Wayne and Hayes [15], conditions known to cause
up-regulation of the DosR regulon [9,10]. When M. tuberculosis
H37Rv, a laboratory strain, and CH, a recent clinical isolate
responsible for a large outbreak [21], were exposed in vitro to
these conditions, abundant Nile red-staining lipid bodies were
observed in both strains; respectively, 29% and 42% in NRP1
(168 h), 50% and 65% in NRP2 (288 h), and 41% and 56% in
late NRP2 (504 h). An average of two lipid bodies per cell (range
one to ﬁve) was observed in all samples except for the H37Rv
NRP1 sample in which only one (range one to three) was seen
in positive cells. Thus, NRPM. tuberculosis cultures contain lipid
bodies at levels comparable to those seen in sputum.
Expression Profiling of M. tuberculosis Recovered from
Sputum
If lipid bodies are a biomarker for cells in an NRP state,
then the M. tuberculosis transcripts present in sputum should
be compatible with those observed in NRP in vitro studies
[9,10]. We therefore compared the transcriptome of M.
tuberculosis recovered from human sputum to that obtained
from in vitro aerobic cultures and NRP-inducing conditions
[15]. Twenty sputa were collected from known microscopy-
positive Gambian patients before they started antibiotic
treatment, and the samples were rapidly stabilized against
RNA degradation. Five samples (designated 1, 5, 7, 8, and 9)
were analysed by microarray hybridisation, four with and one
without prior polyadenylation/oligo-dT based ampliﬁcation.
Although the results from sputum 1, the single direct
(nonampliﬁed) array, are not discussed further, they conﬁrm
the essential details of the ampliﬁed analyses (Tables S1 and
S2). This high-volume sample (;30 ml) had an exceptionally
high bacterial load, and we estimate that .1010 bacilli were
present. The data from the four ampliﬁed samples were
analysed with array hybridisations of ampliﬁed RNA ex-
tracted fromM. tuberculosisH37Rv under different conditions:
log-phase aerobic growth, the two stages of NRP (NRP1 t¼ 72
h; NRP2 t¼ 240 h) [15], and a mixed preparation containing
RNA from aerobic and NRP2 cells mixed in the proportion
70:30 (w/w total RNA). This latter preparation was included
PLoS Medicine | www.plosmedicine.org April 2008 | Volume 5 | Issue 4 | e750637
Persister-Like Tubercle Bacilli in Sputum
because this mixture was representative of the lipid body–
positive population in sputum. This preparation therefore
enabled us to test the hypothesis that sputum comprises a
mixture of the rapidly and aerobically growing bacilli
expected at the margins of liquefying caseous lesions [2] with
the NRP-like cells indicated by our lipid body studies.
Microarray data analysis revealed that, after ﬁltering to
remove genes with low signals in either channel, 182 genes
were signiﬁcantly induced in sputum compared to aerobic
growth, and 334 genes were signiﬁcantly repressed (Tables S3
and S4). Figure 2 displays the results of gene cluster analysis
of array data from the biological and technical replicates for
these genes across the sputa, NRP and mixed aerobic:NRP2
sample sets. Boxes 1 and 2 highlight gene clusters similarly
regulated in NRP2 and sputum relative to aerobic growth. We
note the large cluster of strongly down-regulated signals in
sputum, a feature lost in box 1 in the 70:30 mix, presumably
due to the aerobic signals obscuring the NRP2 signals. A
similar pattern of differential expression is apparent for the
ampliﬁed RNA from the four sputum samples, even though
they came from separate, untreated patients.
The data show that none of our comparator conditions,
including the 70:30 aerobically replicating:NRP2 mixture,
closely parallel the sputum transcriptome. While signiﬁcant
overlaps between the genes differentially expressed in
sputum were revealed by hypergeometric probability values
(Tables S5 and S6), no single or obvious combination of
deﬁned conditions herein, nor previously reported in vitro or
in vivo, correspond to the signature we have obtained from
sputum. Amongst the different functional categories of genes,
relative to aerobic growth there were signiﬁcant decreases in
expression of genes required for aerobic respiration and
ribosomal function and an increase in transcripts associated
with cholesterol utilisation (Figure 3) [38]. We note also that
genes previously observed to be repressed during bacillary
stasis in a chronic murine infection model [37], nuoB, ctaD,
qcrC, atpA, and atpD, followed this pattern in our data while
narK2 was up-regulated, as was the case in the murine studies.
DosR was the most prominently activated regulon in sputum
(box 2 in Figure 2; Tables S2 and S5), although the level of
activation was lower than in the comparator conditions.
The induction of the isocitrate lyase gene, icl1, is consistent
with the expected shift to utilisation of lipids as a source of
carbon and energy [39]. This in vivo–associated metabolic
pattern has emerged from other in vivo studies [11,12,39–42];
we particularly note the signals indicating cholesterol
utilisation related to the putative KstR regulon [38,43], a
feature that corresponds well with prominent sputum
cholesterol content detected by thin layer chromatography
(NJG, unpublished data) and the presence of this lipid in
pulmonary exudates. The combination of DosR activation,
lipid utilisation, and a slow growth signature is similar to
experimental conditions previously studied in animal and
macrophage infections [11,12], as depicted in Figures 3 and 4.
Figure 1. Lipid Bodies in Tuberculous Sputum Samples
Auramine/Nile red-fixed sputum smears [5] and aerobic M. tuberculosis growth. Variation in lipid bodies per cell: (A) none, (B) three, (C) five, and (D)
eight. Samples are shown with (E) low and (F) high proportions of lipid body–positive cells. (G) Aerobically grown mid-log M. tuberculosis H37Rv
contained negligible lipid bodies. Scale bar 2lm.
doi:10.1371/journal.pmed.0050075.g001
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However, induction of Fe2þ scavenging was absent from our
dataset, presumably due to an excess of available Fe2þ in
necrotic liquefying tissue (Tables S3–S6).
We have conﬁrmed key features of the sputum tran-
scriptome and its relation to the metabolic states of bacilli in
sputum with selected qRT-PCR analyses applied to up- and
down-regulated transcripts (Figure 5). Up-regulation of tgs1
was detected in unampliﬁed (Table S1) and ampliﬁed (Table
S3) array analyses and qRT-PCR conﬁrmed this in these and
four further samples (designated 2–4 and 6). While the up-
regulation of icl1 conﬁrms the shift towards lipid utilisation,
the strong hspX (a-crystallin homologue), narK2 (nitrate/
nitrite transporter), and tgs1 transcript signals conﬁrm DosR
up-regulation [8]. Down-regulation of nuoB (type-I NADH
dehydrogenase), qcrC (cytochrome bc1 complex), and ctaD (aa3-
type cytochrome c oxidase) conﬁrms a reduction in efﬁciency
of the aerobic respiratory chain [37].
The strong expression of tgs1 in sputum and the presence of
lipid body–positive M. tuberculosis cells therein suggest a likely
direct link between tgs1 expression, lipid body formation, and
increased bacillary triacylglycerol content. We have demon-
strated such a link in M. smegmatis by overexpressing tgs1 in
this organism (see Figure S1): both increased triacylglycerol
and lipid body content were observed following tgs1 induction.
Figure 2. Display of Genes Differentially Regulated in Sputum and NRP versus Aerobic Culture
Clustering of 648 genes significantly differentially expressed in either sputum, NRP1, NRP2, or a 70:30 mix of aerobic:NRP2 compared to aerobic growth.
Biological and technical replicates of conditions are displayed as columns, genes as rows. Red represents the induction of gene expression relative to
aerobic growth, green repression. Asterisked columns mark the conditions in which genes were identified as significantly differentially expressed
compared to aerobic growth. Boxes 1 and 2 highlight clusters of genes similarly regulated in NRP2 and sputum.
doi:10.1371/journal.pmed.0050075.g002
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The Frequency of Lipid Body–Positive Acid-Fast Bacilli in
Sputum Is Correlated with ‘‘Time to Positivity’’ in Routine
Diagnostic Liquid Culture
Although both the lipid body and the transcriptome results
are consistent with the presence of a NRP-like population in
sputum, more direct evidence that the lipid body–positive
cells have the properties one might expect of cells in this state
would be desirable. Standard bacteriology tells us that
nonreplicating bacterial cells take longer to initiate growth
than their replicating counterparts (longer lag phase) [44,45].
If the lipid body–positive cell count provides an estimate of a
NRP population in sputum, then this should be reﬂected in
the ‘‘time to positivity’’ in liquid culture. Figure 6 demon-
strates that ‘‘time to positivity’’ is signiﬁcantly associated with
lipid body percentage in 15 diagnostic samples with p , 0.03
and R2 ¼ 0.64.
Discussion
We applied a combination of ex vivo and in vitro analyses
to study the phenotypes of M. tuberculosis cells in smear-
positive sputum samples. We found a subpopulation of lipid
body–positive acid-fast cells in all samples for which .100
bacilli were analysable. Our further in vitro studies revealed
nonreplicating persistence, as deﬁned by Wayne and
colleagues [46], to be a condition in which M. tuberculosis cells
are induced to form lipid bodies at frequencies comparable
to those observed among tubercle bacilli in sputum.
Consistent with this ﬁnding, transcriptome analysis of M.
tuberculosis in sputum revealed signals compatible with slow or
non-growth and absence of aerobic respiration. Moreover,
the time to positivity in diagnostic liquid culture was shown
to be directly related to sputum lipid body content, adding
further weight to the view that lipid body–positive cells are
not replicating. While other explanations remain possible, we
conclude that the lipid body–positive cells in sputum have a
persister-like phenotype, with important implications for the
treatment and transmission of tuberculosis. Further studies
should elucidate the impact of chemotherapy on the
frequency of lipid body–positive populations of M. tuberculosis
in patient sputum, and the relationship between this
candidate biomarker and both infectivity and the clinical
response to treatment.
The analysis of tuberculous sputum has played a central
Figure 3. Genes Required for Aerobic Respiration and Ribosomal
Function Show Decreased Expression in Sputum Compared with Aerobic
Growth while Genes Involved in Lipid Metabolism Were Induced
Box and whisker plots showing the distribution of expression ratios (log2
scale) of (A) 21 aerobic respiration genes and (B) 45 ribosomal genes in
NRP2 and sputum relative to aerobic growth using functional
classifications defined by Cole et al., 1998 [24]; also (C) 64 genes that
may be involved in cholesterol catabolism [38] and (D) 45 genes in the
fadB, echA, fadE, and fadA families, which may be involved in the b-
oxidation of fatty acids. *Significant difference (p , 0.01) between NRP2
or sputum compared to aerobic; #Significant difference (p , 0.01)
between NRP2 and sputum.
doi:10.1371/journal.pmed.0050075.g003
Figure 4. Gene Expression Signatures Representative of Slow Growth
and the M. tuberculosis In Vivo Phenotype Were Identified in the Sputum
Transcriptome
The distribution of expression ratios (log2 scale) of (A) 129 genes
repressed and (B) 127 genes induced by slow growth [53]; (C) 106 genes
repressed and (D) 85 genes induced by NRP2 compared to aerobic
growth (this report); (E) 111 genes repressed and (F) 339 genes induced
on murine macrophage infection [12]. In all plots the y-axis denotes fold
change, boxes encompass the 25th and 75th percentiles, whiskers have
been set at 1.53 the range between these values, and only outliers are
shown as individual points. *Significant difference (p , 0.01) between
NRP2 or sputum compared to aerobic; #Significant difference (p , 0.01)
between NRP2 and sputum.
doi:10.1371/journal.pmed.0050075.g004
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role in the diagnosis and management of tuberculosis. While
the presence of acid-fast bacilli in sputum is the feature most
prominently linked to the potential of a patient to dissem-
inate infection, there are other inﬂuential factors. Setting
aside those associated with human behaviour and the
immediate atmospheric conditions, a transmitted tubercle
bacillus must survive transit and master new environmental
pressures if it is to establish infection in a new individual.
From what we know about bacterial adaptation, it is highly
probable that speciﬁc traits are expressed to achieve this
ability. Furthermore, it is recognised that in the treatment of
tuberculosis and other bacterial infections, bacterial burden
correlates not only with increased potential for onward
transmission, but also with the duration of chemotherapy
required for a cure [47]. Bacterial populations often show
heterogeneous properties. The presence of a slow or non-
growing subpopulation of bacteria phenotypically resistant to
antibiotics has been proposed to account for the extended
time required for treatment of tuberculosis [4,48]. Although
never directly identiﬁed, the presence of such a population is
inferred from the biphasic reduction of viable bacterial
counts recovered from serial sputum samples collected
during therapy [4]. Such antibiotic-tolerant ‘‘persister’’
populations have been recognised in many bacterial infec-
tions [49]; a greater bacterial burden being associated with a
higher frequency of phenotypic resistance. The results we
present here are a ﬁrst step towards deﬁning the transmission
phenotype of M. tuberculosis and also reveal directly, to our
knowledge for the ﬁrst time, a substantial population of
persister-like bacilli in sputum prior to commencement of
therapy.
Lipid bodies must now be recognised as a universal feature
of smear-positive tuberculosis, and the signiﬁcance of this
ﬁnding and of the variation in the proportion of positive cells
between samples must be established. While lipid bodies are a
well-established feature of eukaryotic cell biology [50], their
recognition in prokaryotes is relatively recent [51]. The link
between tgs1, the DosR regulon, the hypoxia-induced NRP
state, and lipid bodies that is strengthened and made
clinically relevant by our ﬁndings, relates these structures to
a coherent set of laboratory studies. Lipid body–positive cells
must now be factored into the debate about mycobacterial
dormancy and persistence. Fourteen functional Tgs enzymes
that are not DosR regulated have been identiﬁed [7].
However, none of the mRNAs encoding these enzymes was
found to be up-regulated in our transcriptional studies, while
Tgs1, the most active enzyme, and the DosR regulon itself
were.
While the microarray results can be analysed in several
different contexts, we focus here on the data that have a
bearing on the growth state and lipid body content of our
samples. The transcriptome clearly shows that the sputum
Figure 5. Specific Transcript Ratios for tgs1, hspX, icl1, nuoB, qcrC, and ctaD in AFB-Positive Sputum Samples Determined by qRT-PCR and Normalized to
Values for Aerobically Grown Mid-Log M. tuberculosis H37Rv
Individual target gene transcript copy numbers were normalized against transcript copy numbers of sigA in the samples concerned. Numbers on the
abscissa refer to the designated sputum sample numbers.
doi:10.1371/journal.pmed.0050075.g005
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bacillary population is dominated by slowly or nonreplicating
bacilli, a contention further supported by two lines of
comparative evidence. Firstly, two in vitro transcriptome
datasets can be robustly argued to represent nonreplicating
cell populations: the nutrient deprivation studies of Betts et
al. [52] and our NRP2 results. Of the repressed 33 genes
common to both of these datasets, 20 were found to be down-
regulated in our sputum samples (hypergeometric p-value
2.56 3 1011), a feature that is further supported by strong
correlations with the recently published reduced growth rate
dataset (Figure 5) [53]. Secondly, Shi and colleagues studied
speciﬁc gene expression in chronic mouse infections [37]
under conditions in which there is clear evidence for lack of
replication [54]. In common with this study, our results show
repression of nuoB, ctaD, qcrC, atpA, and atpD and up-
regulation of narK2. This supports the view that our sputum
samples contained many nonreplicating bacilli in respiratory
state III deﬁned by these authors [37], that is, a shift from
oxygen electron transfer to anaerobic electron transfer.
If the frequency of lipid body–positive mycobacteria in
sputum provides an estimate of the NRP cells present, then
other NRP-related features should be correlated. Remarkably,
we found this to be the case with time to positivity in routine
diagnostic cultures performed on samples that we had
analysed for their lipid body content (Figure 6). These results
provide direct evidence that the frequency of lipid body–
positive cells provide an estimate of the nonreplicating
mycobacterial population in sputum in these samples.
Drawing all these results together, we now reject the
commonly held belief that smear-positive sputum is domi-
nated by aerobically replicating Mycobacterium tuberculosis. The
transcriptome data in particular show that such cells could
only be a minor component in the samples analysed in this
way. In contrast, we conclude that our samples contained
nonreplicating mycobacteria at levels proportional to the
lipid body-positive cells therein.
While the signiﬁcance of this ﬁnding to clinical tuber-
culosis will only be established by long-term studies, several
important implications can be recognised at this stage. First,
it is clear that the large numbers of tubercle bacilli observed
in sputum are not a direct sample from extensive and rapid
aerobic growth at the margins of open cavities. Rather, we
propose that, as with all growth in restricted environments,
this aerobic growth results in the buildup of larger and larger
numbers of stationary phase nonreplicating bacilli and that
this accords with the mature ‘‘colony-like’’ growth of tubercle
bacilli reported in caseous lesions by Canetti [2]. Second, the
cidal action of many antibiotics is proportional to the growth
rate of bacteria, with those growing slowly or in a non-
replicating state showing phenotypic tolerance [49,55,56]. In
particular, Wayne type M. tuberculosis NRP cultures are
tolerant to isoniazid and rifampin [15]. Interestingly, while
such cultures provide the closest available transcriptome
match to the signals we have obtained from sputum, our own
studies on phenotypic resistance have so far consistently
shown that the presence of M. tuberculosis lipid bodies
accumulated following growth-arresting stimuli, is correlated
with tolerance to the cidal action of these antibiotics (see
Figure S2). Such phenotypic resistance is widely believed to
underpin the persister phenomenon in tuberculosis, in which
a residual and antibiotic-recalcitrant population requires
extended chemotherapy for its elimination [4].
We emphasise that hypoxia is not the only stress capable of
inducing lipid body formation. This is exempliﬁed by our
preliminary nitric oxide data (Figure S2). This latter effect is
probably mediated via DosR [57]. The relationship between
DosR induction and growth rate is clearly multifactorial, with
the up-regulation of DosR perhaps a general indicator of
mycobacterial stress, for example the DosR regulon is
induced during the exponential phase of growth in mice
[31]. It is the slow/nongrowth transcriptional proﬁle and our
time-to-positivity results that indicate the presence of a
nonreplicating population in sputum rather than dosR
expression, which is found in both growing and nongrowing
populations. However, it should be noted that bacterial
populations are evidently nonuniform. Thus lipid body–
positive cells may also represent a slower or nonreplicating
population within a growing culture.
We cannot say whether the expectorated persister-like
population we report here reﬂects the persister population
revealed during chemotherapy. Initial establishment of
persisters in growing populations is probably random and
at a low level; however, during infection these populations
will be inﬂuenced by speciﬁc conditions, including the
development of colonial/bioﬁlm-like growth [2] and inﬂam-
matory responses that may increase the numbers of persister-
like cells observed [49,57]. We note that all the sputum
samples we examined were collected prior to the commence-
ment of chemotherapy; the status of bacilli within patients
treated with antibiotics is not clear. Nonetheless, this
question is amenable to further study through the analysis
of the responses of patients to therapy and serial analyses of
the lipid body content of their sputum samples.
Finally, returning to the proposal that the bacilli in sputum
display traits that underpin the transmission of tuberculosis,
the relative resistance of nonreplicating bacteria, including
M. tuberculosis, to a variety of stresses is well established [59–
61]. Global stress resistance will promote survival that is
essential for transmission. More speciﬁcally, we note that
formation of lipid bodies in Rhodococcus, another actino-
moycete, has been linked to improved survival during
desiccation [62]. Even more intriguing is the observation that
Figure 6. Time to Positivity in BACTEC 960 Cultures Related to Lipid Body
Counts Determined in the Samples fromWhich the Cultures Were Prepared
Analysis was confined to samples graded 3þ by microscopy to minimize
the effect of varying bacterial inoculum on time to positivity.
doi:10.1371/journal.pmed.0050075.g006
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hypoxically grown M. tuberculosis cultures, in which we have
demonstrated ;34% lipid body–positive cells (unpublished
data), are 10-fold more infectious for guinea pigs by the
aerosol route than their aerobically grown counterparts [63].
Moreover, recent investigation of Beijing strains of M.
tuberculosis revealed that they accumulate more triacylglycerol
and express tgs1 at levels 10-fold higher than laboratory
strains, during aerobic log-phase growth [64]. The enhanced
transmissibility, evidenced by the rapid global spread of these
strains, may reﬂect a greater propensity for lipid body
formation in vivo.
We propose that lipid body positive (fat) acid fast bacilli are
a biomarker for nonreplicating (lazy) M. tuberculosis cells in
sputum; their further study offers exciting and tractable
avenues for research into the treatment and prevention of
tuberculosis.
Supporting Information
Figure S1. Overexpression of tgs1 in M. smegmatis Leads to Enhanced
Accumulation of Triacylglycerol and Lipid Bodies
We cloned tgs1 under the control of the acetamide-inducible
promoter pSD26 [65] and expressed it in Mycobacterium smegmatis,
which readily forms tiacylglycerol (TAG) lipid bodies in vitro. Test
and control cells were exposed to radiolabelled oleic acid for 10 min
and incorporation into TAG determined [66].
(A) Triacylglycerol synthase (TGS) activity of induced MspSD26-tgs1
and MspSD26 vector control, p , 0.001.
(B) Pseudo-coloured ﬂuorescence images of induced MspSD26 vector
control (i) and MspSD26-tgs1 (ii) incubated with 630 lM oleic acid for
10 min and labelled with Nile red [5]. Pseudo-colour (blue/min to red/
max) was applied to grey levels 101–255 to demonstrate enhanced
lipid body formation in the tgs1-overexpressing cells. Scale bar ¼ 2
lm.
Found at doi:10.1371/journal.pmed.0050075.sg001 (6.7 MB TIF).
Figure S2. Nitric Oxide Exposure Stimulates Lipid Body Formation
and Tolerance to the Cidal Action of Rifampin
Exponential phase M. tuberculosis H37Rv cultures in Sauton’s medium
(;105 cfu/ml) were treated with 100 lM spermine.NO (NO donor) for
4 or 24 h. These test cultures respectively contained 65% and 22%
lipid body–positive cells, while the control cultures, exposed to 100
lM spermine.HCl for the same times, contained , 1% . Subsequent
exposure of test and control cultures to rifampin (1 lg/ml) for 7 d
revealed diminished killing in the NO exposed cultures. Error bars¼
þ 1 standard deviation (n ¼ 3).
Found at doi:10.1371/journal.pmed.0050075.sg002 (194 KB TIF).
Table S1. Genes Determined to Be Greater than 3-fold Up-regulated
in Sputum 1 Compared with In Vitro Growth of the Cognate Isolate
by Direct Microarray
Found at doi:10.1371/journal.pmed.0050075.st001 (52 KB DOC).
Table S2. Hypergeometric Probability Analysis of Genes Determined
to be . 3-Fold Up-regulated in Sputum 1 Compared to In Vitro
Cognate Isolate Growth by Direct Microarray
Found at doi:10.1371/journal.pmed.0050075.st002 (85 KB DOC).
Table S3. Genes Determined to be Greater than 2.5-Fold Up-
regulated in Sputum Compared with In Vitro Growth by Ampliﬁed
Microarray
Found at doi:10.1371/journal.pmed.0050075.st003 (403 KB DOC).
Table S4. Genes Determined to be Greater than 2.5-fold Down-
regulated in Sputum Compared with In Vitro Growth by Ampliﬁed
Microarray
Found at doi:10.1371/journal.pmed.0050075.st004 (664 KB DOC).
Table S5. Hypergeometric Probability Analysis of Genes Determined
to be .2.5-Fold Up-regulated in Sputum Compared to In Vitro
H37Rv Growth by Ampliﬁed Microarray
Found at doi:10.1371/journal.pmed.0050075.st005 (104 KB DOC).
Table S6. Hypergeometric Probability Analysis of Genes Determined
to be .2.5-Fold Down-regulated in Sputum Compared to In Vitro
H37Rv Growth by Ampliﬁed Microarray
Found at doi:10.1371/journal.pmed.0050075.st006 (86 KB DOC).
Accession Numbers
The fully annotated microarray data from this study are deposited in
BlG@Sbase (accession number: E-BUGS-52; http://bugs.sgul.ac.uk/
E-BUGS-52) and ArrayExpress (accession number: E-BUGS-52; http://
www.ebi.ac.uk/arrayexpress/experiments/E-BUGS-52).
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Editors’ Summary
Background. Every year, nearly nine million people develop tuber-
culosis—a contagious infection usually of the lungs—and about two
million people die from the disease. Tuberculosis is caused by
Mycobacterium tuberculosis, bacteria that are spread in airborne droplets
when people with the disease cough or sneeze. The symptoms of
tuberculosis include a persistent cough, weight loss, and night sweats.
Diagnostic tests include chest X-rays, the tuberculin skin test, and
sputum analysis. For the last of these tests, a sample of sputum (mucus
and other matter brought up from the lungs by coughing) is collected
and then taken to a laboratory where bacteriologists look for M.
tuberculosis using special stains—tuberculosis-positive sputum contains
‘‘acid-fast bacilli’’—and also try to grow bacteria from the sample.
Tuberculosis can be cured by taking several powerful antibiotics for
several months. It is very important that this treatment is completed to
ensure that all the M. tuberculosis bacteria in the body are killed and to
prevent the emergence of drug-resistant bacteria.
Why Was This Study Done? Strenuous efforts are being made to reduce
the global burden of tuberculosis but with limited success so far for
many reasons. One barrier to success is the efficiency with which M.
tuberculosis spreads from one person to another. Very little is known
about this part of the bacteria’s life cycle. If scientists could understand
more about the transmission of M. tuberculosis between people, they
might identify new therapeutic and preventative targets. In the study,
therefore, the researchers examine the acid-fast bacilli in tuberculosis-
positive sputum samples to get a snapshot of M. tuberculosis at the point
of its transmission to a new person and ask how the characteristics of
these bacilli compare with those of M. tuberculosis growing in the
laboratory.
What Did the Researchers Do and Find? The researchers collected
sputum samples from patients with tuberculosis in the UK and The
Gambia before they received any treatment, and looked for the presence
of acid-fast bacilli containing ‘‘lipid bodies.’’ These small structures
contain a fat called triacylglycerol. M. tuberculosis accumulates triacyl-
glycerol when it is exposed to several stresses present during infection
(for example, reduced oxygen or hypoxia) and the researchers suggest
that the presence of this fat may help the bacteria survive during
transmission and establish a new infection. They found that all the
samples contained some lipid body–positive acid-fast bacilli. Next, the
researchers showed that M. tuberculosis grown in the laboratory under
hypoxic conditions, which induce the bacteria to enter an antibiotic-
tolerant condition called a ‘‘nonreplicating persistent’’ (NRP) state, also
accumulated lipid bodies. This result suggests that the lipid body–
positive acid-fast bacilli in sputum might be in an NRP state. To test this
idea, the researchers compared the pattern of mRNAs (the templates
from which proteins are produced; the pattern of mRNAs is called the
transcriptome and gives an idea of which proteins a cell is making under
given conditions) made by growing cultures of M. tuberculosis, by M.
tuberculosis maintained in the NRP state, and by the acid-fast bacilli in
several sputum samples. The transcriptome of the sputum sample
revealed production of many proteins made in the NRP state. Finally, the
researchers showed that the time needed to grow M. tuberculosis from
sputum samples increased as the proportion of lipid body–positive acid-
fast bacilli in the sputum increased, just as one would suspect if the
presence of lipid bodies signifies nongrowing cells.
What Do These Findings Mean? It has been generally assumed that the
acid-fast bacilli in sputum collected from patients with tuberculosis are
rapidly replicating M. tuberculosis released from infected areas of the
lungs. By identifying a population of bacteria that contain lipid bodies
and that are in an NRP-like state in all the samples of sputum examined
from two geographical sites, this study strongly challenges this
assumption. The characteristics of this population of bacteria, the
researchers suggest, might help them survive the adverse conditions
that M. tuberculosis encounters during transmission between people and
might partly explain why complete clearance of M. tuberculosis requires
extended treatment with antibiotics. To establish the clinical significance
of these findings, future studies will need to examine whether antibiotic
treatment affects the frequency of lipid body–positive M. tuberculosis
bacteria in patients’ sputum and whether there is any relationship
between this measurement and infectiousness, or clinical response to
treatment.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050075.
 The MedlinePlus encyclopedia contains pages on tuberculosis and on
sputum culture (in English and Spanish)
 The US National Institute of Allergy and Infectious Diseases provides
information on all aspects of tuberculosis
 The US Centers for Disease Control and Prevention Division of
Tuberculosis Elimination provides several fact sheets and other
information resources about tuberculosis
 The World Health Organization provides information on efforts to
reduce the global burden of tuberculosis
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